Funding News
Nua Raises $50 Million in Series C Led by Peak XV and Filter Capital — India's Leading Women's Wellness Brand Has Grown Its Revenue 5x to Rs 500 Crore in Two Years While Staying Profitable
By Mustafa Shariff, Editor in Chief · September 21,2026 · 2 mins read
Summary
- Nua Raises $50M Series C Led by Peak XV and Filter Capital — India's Women's Wellness Brand Grows Revenue 5x to Rs 500 Crore While Profitable
- Nua raised $50M Series C (Peak XV Partners, Filter Capital) — Mumbai women's wellness brand with ARR Rs 500 crore (5x in 24 months, profitable), 3M+ women/month, expanding period care, maternity, intimate wellness across quick commerce and offline channels.
"This round validates what we have always believed: that there is an enormous, underserved market of women in India who want products built around their specific needs — not adapted from products designed for someone else. We started with period care because it was the most basic, most universal, and most overlooked need. We have expanded into maternity care and everyday intimate wellness because those are the next chapters in the same journey. The capital from Peak XV and Filter Capital will accelerate our product R&D, expand our distribution across quick commerce and offline pharmacy channels, and let us build the brand presence that India's women's wellness category deserves."
Nua, the Mumbai-based digital-first omnichannel women's wellness brand founded in 2017 by Ravi Ramachandran and Abhishek Ramanathan, raised $50 million (approximately Rs 472 crore) in a Series C funding round on September 7, 2026 — led by Peak XV Partners (formerly Sequoia India) and Filter Capital, with participation from existing investors Mirabilis Investment Trust and Footpath Ventures.
The Commercial Case: 5x Revenue Growth While Profitable
The number that defines Nua's Series C is not the $50 million raised — it is the commercial performance that justified it. Nua has grown its annualised revenue run rate from Rs 100 crore to Rs 500 crore over the past 24 months — a fivefold increase — while remaining profitable throughout. This combination of hypergrowth and profitability before a large institutional round is exceptional in India's consumer healthtech landscape. Profitability before a Series C is not the norm; doing it while growing 5x in two years is rarer still.
What Nua Sells
Nua began in 2017 as a period care brand — offering ultra-thin sanitary pads with zero irritation and a subscription model that was novel in India's feminine hygiene market. The company has since expanded into maternity care (pregnancy, postpartum, and infant care products) and everyday intimate care. It also operates the Nua Period Tracker App and SecretKeeper chat — building a digital relationship with its 3 million-plus monthly users that extends beyond the physical products.
Nua competes with established sanitary care brands (Whisper, Stayfree, Sofy — Procter & Gamble, J&J, Kao) as well as newer women's wellness companies including Plush, Azah, Pee Safe, and Carmesi. The $50 million Series C gives Nua a capital position to accelerate its brand-building investment significantly relative to these competitors.
The Use of Funds
Nua will deploy the capital across three priorities: brand building (above-the-line advertising investment to build mass-market awareness beyond its core digital-first customer base), distribution expansion (deepening quick commerce penetration — Zepto, Blinkit, Swiggy Instamart — and expanding offline pharmacy and modern trade distribution), and R&D and new product development across period care, maternity care, intimate care, and adjacent women's wellness categories.
India's Femtech Market Context
India's femtech market — which spans period care, maternity, menopause, fertility, intimate health, and women's diagnostics — is projected to grow at a compound annual growth rate of 15.7% between 2026 and 2034 to reach $5.5 billion by the end of that period, according to IMARC Group. The funding momentum within this sector in 2026 has been significant: Pee Safe raised $32 million from OrbiMed in January 2026 to expand its offline retail footprint, Healthfab raised Rs 20 crore for its menstrual wellness product portfolio, and now Nua's $50 million — the largest single round in India's femtech sector in 2026.
BHC Perspective
At Bengaluru Health Community, Nua's $50 million Series C is the India femtech success story of 2026. A Rs 500 crore annualised revenue business, profitable, growing 5x over two years, now backed by Peak XV and Filter Capital — this is the commercial outcome that validates the entire women's wellness investment thesis. For BHC's women's health founders — Nua's trajectory from period care startup to omnichannel women's wellness platform is the commercial roadmap. For BHC's HMEP students — Nua's customer-centricity, D2C brand building, and omnichannel distribution strategy is a masterclass in building a consumer healthcare brand in India.
FAQs
Q: What did Nua raise?
A: $50 million (Rs 472 crore) Series C led by Peak XV Partners and Filter Capital, with Mirabilis Investment Trust and Footpath Ventures participating. Mix of primary capital and secondaries (partial exits for Kae Capital, Lightbox VC, angels). Announced September 7, 2026.
Q: What are Nua's commercial metrics?
A: ARR Rs 500 crore (5x from Rs 100 crore in 24 months) while remaining profitable. 3 million+ women and girls served monthly. Products: period care, maternity care, everyday intimate care, skincare. Also: Nua Period Tracker App and SecretKeeper chat.
Q: What is India's femtech market size?
A: Projected to grow at 15.7% CAGR between 2026-2034 to reach $5.5 billion. 2026 context: Pee Safe raised $32M (OrbiMed, January), Healthfab raised Rs 20 crore (Series A, May), Nua raised $50M (Peak XV + Filter, September) — India's largest femtech round of 2026.